Cited by 256Probiotics and Fermented FoodsGut microbiota and healthTryptophan and brain disorders

Gut feelings: a randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms

Open access
Chahwan, Bahia, Kwan, Sophia, Isik, Ashling, van Hemert, Saskia, Burke, Catherine, Roberts, Lynette·2019·Journal of Affective Disorders

Abstract

BACKGROUND: Depression is the leading cause of disability worldwide; with evidence suggesting that decreased gut barrier function and inflammation are correlated with depressive symptoms. We conducted a clinical trial to determine the effect of consumption of probiotic supplements (Winclove's Ecologic® Barrier) on depressive symptoms in a sample of participants with mild to severe depression. METHOD: 71 participants were randomly allocated to either probiotic or placebo, which was, consumed daily over eight weeks. Pre- and post-intervention measures of symptoms and vulnerability markers of depression as well as gut microbiota composition were compared. Clinical trial participants were also compared on psychological variables and gut microbiota composition to a non-depressed group (n = 20). RESULTS: All clinical trial participants demonstrated improvement in symptoms, suggesting non-specific therapeutic effects associated with weekly monitoring visits. Participants in the probiotic group demonstrated a significantly greater reduction in cognitive reactivity compared with the placebo group, particularly in the mild/moderate subgroup. Probiotics did not significantly alter the microbiota of depressed individuals, however, a significant correlation was found between Ruminococcus gnavus and one depression metric. LIMITATIONS: There was a high attrition rate, which may be attributed to weekly monitoring visits. Additionally, modulation of the gut microbiota may need more specific testing to distinguish subtle changes. CONCLUSIONS: While microbiota composition was similar between all groups, probiotics did affect a psychological variable associated with susceptibility to depression. Further research is needed to investigate how probiotics can be utilised to modify mental wellbeing, and whether they can act as an adjunct to existing treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2019.04.097

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Casertano et al. (2024) and Chahwan et al. (2019) reported reductions in maladaptive cognitive reactivity and rumination without broad mood changes.

    “Casertano et al. (2024) and Chahwan et al. (2019) reported reductions in maladaptive cognitive reactivity and rumination without broad mood changes”

    From Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis (2026) · cites this paper as Chahwan et al. (2019)

    The Secondary outcomes section reports lower cognitive reactivity after probiotics than after placebo, particularly among participants with mild or moderate depression, but not those with severe depression. The Discussion reports no greater reduction in depressive symptoms, anxiety, or stress than with placebo. The paper does not report a reduction in rumination; rumination appears only in a cited reference title. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In that trial, probiotics did not significantly alter microbiota composition in depressed participants, though a correlation was found between Ruminococcus gnavus and one depression metric.

    “However, probiotics did not significantly alter the microbiota composition in the depressed participants, though a correlation was found between Ruminococcus gnavus and one depression metric.”
  • Psychobiotics can positively affect psychological variables related to depression susceptibility.

    “Despite a high attrition rate and the need for more specific microbiota analysis, the study suggests that psychobiotics can positively affect psychological variables related to depression susceptibility.”
  • In a clinical trial of Ecologic® BARRIER in individuals with mild to severe depression, those in the psychobiotic group experienced a significantly greater reduction in cognitive reactivity, particularly in those with mild to moderate depression.

    “While all participants showed some improvement, those in the psychobiotic group experienced a significantly greater reduction in cognitive reactivity, particularly in those with mild to moderate depression.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 106 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Chahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L.
Affiliations
University of Technology Sydney (AU)
Corresponding author
  • Burke, Catherine
  • Roberts, Lynette
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2019-06
Volume
253
Pages
317-326
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2944223773
Cited by
256
References
106
Citations by year
2026: 18 · 2025: 41 · 2024: 43 · 2023: 49 · 2022: 39 · 2021: 43 · 2020: 18 · 2019: 4 · 2017: 1
FWCI
20.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
probiotics, depressive symptoms, depression, gut microbiota, Ruminococcus gnavus, cognitive reactivity, intestinal barrier, inflammation, gut-brain axis
MeSH terms
Gastrointestinal Microbiome, Adult, Depression, Female, Humans, Male, Placebos, Research Design, Dietary Supplements, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review